Assessment of correlation between in vitro CD3 + T cell susceptibility to EAV infection and clinical outcome following experimental infection

Veterinary Microbiology

Volumn 157, Issue 1-2, 2012, Pages 220-225

  Go, Yun Young ^a,b   Cook, R Frank ^a   Fulgêncio, Juliana Q ^a,c   Campos, Juliana R ^a   Henney, Pamela ^a   Timoney, Peter J ^a   Horohov, David W ^a   Balasuriya, Udeni B R ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

CD3 + T lymphocytes; Cytokines; Equine arteritis virus; Equine viral arteritis; Genetic susceptibility

Indexed keywords

MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD3+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DISEASE SEVERITY; EQUINE VIRAL ARTERITIS VIRUS; EXPERIMENTAL INFECTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HORSE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INFECTION; VIRUS REPLICATION; VIRUS SHEDDING;

ANIMALS; ANTIGENS, CD3; ARTERITIS VIRUS, EQUINE; ARTERIVIRUS INFECTIONS; CYTOKINES; DISEASE SUSCEPTIBILITY; FEMALE; HAPLOTYPES; HORSE DISEASES; HORSES; IMMUNITY, INNATE; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE COUNT; PHENOTYPE; T-LYMPHOCYTES; VIRUS SHEDDING;

EQUIDAE; EQUINE ARTERITIS VIRUS;

EID: 84859727510     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2011.11.031     Document Type: Article

References (13)

1. Balasuriya U.B., MacLachlan N.J. The immune response to equine arteritis virus: potential lessons for other arteriviruses. Vet. Immunol. Immunopathol. 2004, 102:107-129.
2. Balasuriya U.B., MacLachlan N.J. Infectious Diseases of the Horse 2007, Elsevier.
3. Balasuriya U.B., Snijder E.J., Heidner H.W., Zhang J., Zevenhoven-Dobbe J.C., Boone J.D., McCollum W.H., Timoney P.J., MacLachlan N.J. Development and characterization of an infectious cDNA clone of the virulent Bucyrus strain of Equine arteritis virus. J. Gen. Virol. 2007, 88:918-924.
4. Chambers T.M., Quinlivan M., Sturgill T., Cullinane A., Horohov D.W., Zamarin D., Arkins S., Garcia-Sastre A., Palese P. Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses. Equine Vet. J. 2009, 41:87-92.
5. + T cell susceptibility/resistance to equine arteritis virus infection. J. Virol. 2011, (Epub ahead of print, October 12).
6. + T lymphocytes and CD14+ monocytes. J. Virol. 2010, 84:4898-4911.
7. t) method. Methods 2001, 25:402-408.
8. Maloy K.J., Powrie F. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2001, 2:816-822.
9. Neu S.M., Timoney P.J., McCollum W.H. Persistent infection of the reproductive tract in stallions experimentally infected with equine arteritis virus. Proceedings of the 5th International Conference Equine Infectious Diseases 1987, 149-154.
10. Ramakers C., Ruijter J.M., Deprez R.H., Moorman A.F. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci. Lett. 2003, 339:62-66.
11. Senne D.A., Pearson J.E., Carbrey E.A. Equine viral arteritis: a standard procedure for the virus neutralization test and comparison of results of a proficiency test performed at five laboratories. Proceedings of the 89th Annual Meeting of the United States Animal Health Association 1985, 29-34.
12. Timoney P.J., McCollum W.H. Equine viral arteritis. Vet. Clin. North Am. 1993, 295-309.
13. Zhang J., Go Y.Y., MacLachlan N.J., Meade B.J., Timoney P.J., Balasuriya U.B. Amino acid substitutions in the structural or nonstructural proteins of a vaccine strain of equine arteritis virus are associated with its attenuation. Virology 2008, 378:355-362.